Intercept Pharmaceuticals, Inc. ICPT
19.00 0.00 0.00%
At close · Nov 7
52-week range unavailable
- Open
- 19.00
- Prev close
- 19.00
- Mkt cap
- 794.69M
- Vol
- 3.91M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.98
- High
- 19.01
- Forward P/E
- 8.88
- Beta
- 0.88
- Short ratio
- 5.54
- Inst. own
- 81.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2023
- 50-d avg
- 16.63
- 200-d avg
- 14.55
- 1y target
- 19.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ICPT has not been loaded yet. Try again in a moment.
Altman Z-Score
-5.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 3.6×
P/S 1.5×
P/B 4.5×
P/FCF -15.3×
EV/EBITDA -4.6×
EV/Sales 2.5×
FCF Yield -6.5%
Gross Margin 99.7%
Operating Margin -23.9%
Net Margin 40.3%
ROE 123.7%
ROIC 10.4%
ROA 20.8%
Revenue -21.4%
Operating Income -22.3%
EPS (diluted) 174.7%
Free Cash Flow 34.9%
Current Ratio 2.3×
Quick Ratio 2.3×
Debt / Equity 3.6×
Net Debt / EBITDA -1.8×
Interest Coverage -3.2×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31